, Tracking Stock Market Picks
Enter Symbol:
Somaxon Pharmaceuticals, Inc. (SOMX) [hlAlert]

down 91.07 %

Somaxon Pharmaceuticals, Inc. (SOMX) rated Buy by Merriman Curhan Ford

Posted on: Thursday,  Jun 5, 2008  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) on 06/05/2008, when the stock price was $33.60.
Since then, Somaxon Pharmaceuticals, Inc. has lost 91.07% as of 03/06/2015's recent price of $3.00.
If you would have followed this Merriman Curhan Ford's recommendation on SOMX, you would have lost 91.07% of your investment in 2465 days.

Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. Somaxon's lead product candidate, SILENOR, is in Phase III clinical trials for the treatment of insomnia

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/5/2008 8:25 AM Buy
as of 12/24/2008
1 Week down  -7.50 %
1 Month up  2.77 %
3 Months down  -83.91 %
1 YTD down  -73.18 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy